PINNED
PINNED
Pharma Horizons: leading-edge formulation
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
List view / Grid view
Articles
Quality by Design for generic products: opportunities and challenges
The first part of an in-depth article on Quality by Design (QbD), published in European Pharmaceutical Review in December 2016, focused on designing quality in to a pharmaceutical drug product by considering dosage form design, and understanding the importance of active pharmaceutical ingredients’ (APIs’) and excipients’ properties.
Drawing the boundaries of data disclosure in clinical trials
In the context of clinical trial data disclosure, since 2010 the regulatory impetus has shifted towards enhanced disclosure obligations, culminating in the publication of a ‘pro-active’ policy on the publication of clinical trial data for medicinal products for human use1 (Policy 0070) by the European Medicines Agency (EMA) in October…
Driving business value from pharmaceutical serialisation
15 February 2017 | By Nicolás Giménez Stamminger, Manager IT Advisory, KPMG Switzerland
KMPG’s Nicolás Giménez Stamminger explains why serialisation is the solution to counterfeit medicines and how to implement a cost-effective serialisation strategy…
Looking for life sciences opportunities in a post-Brexit world
13 February 2017 | By Dr Penny Owen, Life Sciences Hub Wales
From government regulation to European trade, Life Sciences Hub Wales chairperson, Dr Penny Owen, looks ahead to the unknown of a post-Brexit world...
Why the Internet of Medical Things is the future of healthcare
10 February 2017 | By Niamh Marriott, Digital Editor
We caught up with Nexeon’s CEO, Will Rosellini, to talk about the Internet of Medical Things - the dangers, the benefits and what the future holds...
2017 pipelines: AstraZeneca – another challenging year
8 February 2017 | By Brian White and Paul Taylor, Healthcare Analysts, Cantor Fitzgerald Europe
Healthcare analysts predict another difficult year ahead for the pharmaceutical giant, after 2016 was beset with competitive and pricing pressures...
Serialisation and Traceability: Knowing your implementation and expenditures
6 February 2017 | By Pasi Kemppainen, Executive Consultant, Pharma Serialisation and Traceability
Pharma serialisation and traceability expert, Pasi Kemppainen, gives us his insights on how to ensure a future-proof and cost-effective strategy
The top 21… wealthiest pharma companies
European Pharmaceutical Review has been keeping the industry informed for 21 years and continues to bring insights into current and emerging technologies, contributions from recognised figures in the life science community and of course, the latest and most up to date news. To celebrate our success, we will be counting down…
Democratising clinical genomics while protecting data privacy
1 February 2017 | By Jurgi Camblong (CEO, Sophia Genetics)
Sophia Genetics co-founder and CEO, Jurgi Camblong, tackles issues of privacy and security for healthcare patient data...
Transforming healthcare in the era of Trump: An opportunity to disrupt
20 January 2017 | By Stephen Klasko, President and CEO, Thomas Jefferson University and Jefferson Health; Editor-in-Chief, Healthcare Transformation
With Trump’s rule imminent, President and CEO of Thomas Jefferson University, Stephen Klasko, puts forth a manifesto for healthcare reform, disruption and change…
The Good, the Bad, and the Donald: what Pharma can expect from 2017
11 January 2017 | By Niamh Marriott, Digital Editor
From an orphan drug sales boom to uncharted political landscapes, the CPhI Worldwide expert panel predict pharma’s biggest opportunities and threats in 2017.
Issue #6 2016 – Digital version
Read the free-to-view digital version of the latest issue of European Pharmaceutical Review...
Raman In-Depth Focus 2016
In this supplement: Raman imaging evaluating counterfeit Cialis® tablets; analysis of capsule-based dry powder inhalers; Raman spectroscopy to authenticate medicines; Raman roundtable; as well as expert views...
Application Notes & Whitepapers 2016
13 December 2016 | By European Pharmaceutical Review
With the huge range of processes involved in drug discovery and manufacture, it's no wonder we had to create a separate magazine for this content – and as such we have a wide variety of applications...
RMMs In-Depth Focus
In this RMMs In-Depth Focus: the role of statistical analysis in validating rapid microbiological methods; considerations when using RMMs for use in pharmaceutical microbiology; & RMMs roundtable...
